Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia

被引:29
|
作者
Silver, Michael [1 ]
Factor, Stewart A. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Neurol, Wesley Woods Hlth Ctr, Atlanta, GA 30329 USA
关键词
Valproic acid; Valproate; Parkinsonism; Dyskinesia; REVERSIBLE PARKINSONISM; SODIUM VALPROATE; EPILEPSY;
D O I
10.1016/j.parkreldis.2013.03.016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Valproic acid is a drug used for the treatment of a variety of psychiatric and neurological disorders. While it is well known to cause postural tremor, hyperammonemia, slowness, and sedation, it has also been described to occasionally cause a reversible form of parkinsonism. Materials and methods: A series of five cases is reported. Results: All patients were taking the drug for at least several months before onset of their parkinsonian symptoms. Parkinsonism was defined by the presence of bradykinesia, rigidity, postural instability, and resting tremor, but not postural or action tremor. After discontinuing their valproic acid, improvement was seen by all patients. The course of improvement took days to months after discontinuance. Two of these patients responded to dopaminergic therapy, with drug-induced dyskinesia observed in one. In another patient, valproic acid was thought to unmask underlying Parkinson's Disease; this patient benefited from levodopa as well. Conclusion: Valproic acid-induced parkinsonism can look identical to idiopathic parkinsonism. In all five cases, the relationship between the valproic acid use and parkinsonism was initially unclear because of the delayed and insidious onset. Our finding of levodopa responsiveness and dyskinesia added to the diagnostic confusion. This treatment responsiveness also set it apart from neuroleptic-induced parkinsonism. In all cases improvement of symptoms occurred after discontinuation of the offending medication. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [21] The valproic acid-induced rodent model of autism
    Nicolini, Chiara
    Fahnestock, Margaret
    EXPERIMENTAL NEUROLOGY, 2018, 299 : 217 - 227
  • [22] Valproic Acid-Induced Acute Liver Failure
    Shahbaz, Omar
    Majumder, Shounak
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S197 - S197
  • [23] Valproic acid-induced tremor and cognitive slowing
    Lamprecht, Ann-Kristin
    Miosge, Ragna-Jill
    Kruemmer, Norma
    Berrouschot, Joerg
    Kleine, Bert-Ulrich
    CLINICAL EPILEPTOLOGY, 2024, 37 (01) : 36 - 40
  • [24] Hyperammonernia and valproic acid-induced encephalopathy - Reply
    Carr, Russell B.
    Shrewsbury, Kerrie
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (12): : 1913 - 1914
  • [25] Valproic acid-induced hyperammonemia - A case report
    McCall, M
    Bourgeois, JA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (05) : 521 - 526
  • [26] INCIDENCE OF VALPROIC ACID-INDUCED HYPERAMMONEMIC ENCEPHALOPATHY
    Dominguez Bertalo, J.
    Carrasco, S.
    Burriel, L.
    Alvarez, M. J.
    Gudin, M.
    Vaamonde, J.
    EPILEPSIA, 2011, 52 : 120 - 120
  • [27] Carnitine in the treatment of valproic acid-induced toxicity
    Lheureux, Philippe E. R.
    Hantson, Philippe
    CLINICAL TOXICOLOGY, 2009, 47 (02) : 101 - 111
  • [28] Valproic acid-induced hearing loss and tinnitus
    Hori, A
    Kataoka, S
    Sakai, K
    Hirose, G
    Iwasaki, N
    Horiguchi, A
    Takashima, M
    Tomoda, K
    INTERNAL MEDICINE, 2003, 42 (11) : 1153 - 1154
  • [29] Valproic acid-induced eosinophilic pleural effusion
    Kravetz, JD
    Federman, DG
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (08) : 803 - 806
  • [30] Epigenetic modifications in valproic acid-induced teratogenesis
    Tung, Emily W. Y.
    Winn, Louise M.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 248 (03) : 201 - 209